Provided by Tiger Trade Technology Pte. Ltd.

Crinetics Pharmaceuticals Inc.

32.92
-1.7100-4.94%
Post-market: 32.920.00000.00%19:59 EDT
Volume:863.20K
Turnover:28.73M
Market Cap:3.47B
PE:-6.42
High:34.80
Open:34.65
Low:32.65
Close:34.63
52wk High:57.99
52wk Low:25.83
Shares:105.44M
Float Shares:96.32M
Volume Ratio:0.76
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.1291
EPS(LYR):-4.9500
ROE:-39.17%
ROA:-24.69%
PB:2.71
PE(LYR):-6.65

Loading ...

Crinetics to present up to 2-year PATHFNDR open-label extension data on oral acromegaly drug Palsonify at ENDO 2026

Reuters
·
Jun 02

Assessing Crinetics Pharmaceuticals (CRNX) Valuation After Q1 2026 Revenue Growth And Wider Net Loss

Simply Wall St.
·
May 16

Crinetics Pharmaceuticals Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
May 16

Crinetics price target lowered to $88 from $89 at Evercore ISI

TIPRANKS
·
May 15

Crinetics Pharmaceuticals : Oppenheimer Cuts Target Price to $84 From $87

THOMSON REUTERS
·
May 11

Crinetics Pharmaceuticals Down Over 14%, on Pace for Largest Percent Decrease Since January 2025 -- Data Talk

Dow Jones
·
May 09

Crinetics Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
May 08

Stock Track | Crinetics Pharmaceuticals Plummets 5.73% Intraday Following Analyst Price Target Reduction

Stock Track
·
May 08

Crinetics price target lowered to $95 from $97 at Citizens

TIPRANKS
·
May 08

Earnings Flash (CRNX) Crinetics Pharmaceuticals Posts Q1 Loss $1.23 a Share, vs. FactSet Est of $1.22 Loss

MT Newswires Live
·
May 08

Crinetics Pharmaceuticals Q1 revenue jumps on Palsonify launch

Reuters
·
May 08

Crinetics Pharmaceuticals Q1 EPS $(1.23) Beats $(1.25) Estimate, Sales $10.306M Beat $8.512M Estimate

Benzinga
·
May 08

BRIEF-Crinetics Pharmaceuticals Q1 Net Income USD -127.845 Million

Reuters
·
May 08

Crinetics Pharmaceuticals Inc - Expects 2026 Gaap Operating Expenses $600 Mln-$650 Mln; Non-Gaap Operating Expenses $480 Mln-$520 Mln

THOMSON REUTERS
·
May 08

Crinetics Pharmaceuticals Q1 Revenue USD 10.306 Million

THOMSON REUTERS
·
May 08

Crinetics Pharmaceuticals Q1 EPS USD -1.23

THOMSON REUTERS
·
May 08

Crinetics Pharmaceuticals announces annual shareholder meeting

Reuters
·
Apr 30

Crinetics Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Apr 28

Crinetics price target raised to $97 from $96 at Citizens

TIPRANKS
·
Apr 28

Crinetics’ Palsonify approved by European Commission for acromegaly

TIPRANKS
·
Apr 28